147 related articles for article (PubMed ID: 2463003)
1. [Collection and transplantation of hematopoietic stem cells of circulating blood].
Körbling M; Fehrentz D; Rother K; Hunstein W
Beitr Infusionsther; 1988; 21():322-34. PubMed ID: 2463003
[No Abstract] [Full Text] [Related]
2. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
3. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia.
Wunder E; Sovalat H; Liang H; Becker M; Henon P
Prog Clin Biol Res; 1994; 389():345-50. PubMed ID: 7535441
[No Abstract] [Full Text] [Related]
4. Collection and use of circulating hematopoietic progenitor cells.
Lee JH; Klein HG
Hematol Oncol Clin North Am; 1995 Feb; 9(1):1-22. PubMed ID: 7737936
[TBL] [Abstract][Full Text] [Related]
5. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases. Report of a symposium, 14 March 1996, Washington, DC.
Beatty PG
Exp Hematol; 1997 Oct; 25(11):1195-208. PubMed ID: 9328457
[No Abstract] [Full Text] [Related]
6. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
Novitzky N; Mohamed R
Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
[TBL] [Abstract][Full Text] [Related]
7. [Clinical use of peripheral stem cells for autologous transplantation].
Zingsem J; Zeiler T; Weisbach V; Holfeld-Ozuysal C; Zimmermann R; Heuft HG; Beyer J; Schwerdtfeger R; Eckstein R
Beitr Infusionsther; 1991; 28():251-3. PubMed ID: 1725632
[TBL] [Abstract][Full Text] [Related]
8. Component processing and intraoperative autotransfusion during bone marrow harvest.
Cook-Craig A; Owen A; Reeder G; Drobyski W; Horowitz M; Brunner J; Flomenberg N; Keever C
Prog Clin Biol Res; 1994; 389():613-9. PubMed ID: 7700927
[No Abstract] [Full Text] [Related]
9. Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients.
Barbot C; Rice A; Vanès I; Mahon FX; Jazwiec B; Reiffers J
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):325-31. PubMed ID: 7971254
[TBL] [Abstract][Full Text] [Related]
10. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
Testa U
Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
[TBL] [Abstract][Full Text] [Related]
11. The use of an expanded circulating hematopoietic progenitor cell pool associated with bone marrow fibrosis for the support of autologous transplantation in IgD multiple myeloma.
de la Serna J; Bornstein R; Lahuerta-Palacios JJ
Bone Marrow Transplant; 1997 May; 19(10):1033-6. PubMed ID: 9169649
[TBL] [Abstract][Full Text] [Related]
12. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
[TBL] [Abstract][Full Text] [Related]
13. Collection, cryopreservation and autologous transplantation with circulating hemopoietic stem cells in patients with multiple myeloma and lymphoma.
Adam M; Benbunan M; Fermand JP; Gisselbrecht C; Sitthy X; Maréchal B; Marchix T; Gerota J
Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():33-4. PubMed ID: 1969307
[No Abstract] [Full Text] [Related]
14. [Collection of hematopoietic stem cells from peripheral blood and retransfusion following myeloablative therapy].
Höcker P; Emminger W; Emminger-Schmidmeier W; Ritschl P; Wagner A; Gerhartl K; Ellend G
Beitr Infusionsther; 1988; 21():335-9. PubMed ID: 2463005
[No Abstract] [Full Text] [Related]
15. Poor stem cell mobilizers--variation in response to G-CSF dose escalation.
Morris T; Ranaghan L; Drake M
Bone Marrow Transplant; 1999 Aug; 24(4):448-9. PubMed ID: 10467343
[No Abstract] [Full Text] [Related]
16. [Long-term cultivation of human bone marrow and its importance for clinical practice].
Mergenthaler HG; Dörmer P
Beitr Infusionsther; 1991; 28():259-64. PubMed ID: 1725634
[TBL] [Abstract][Full Text] [Related]
17. [Hematological recovery after peripheral blood stem cell transplantation followed by recombinant granulocyte colony-stimulating factor].
Fujii H; Nakagawa H; Sonoda Y; Kuzuyama Y
Rinsho Ketsueki; 1993 Aug; 34(8):904-11. PubMed ID: 7692115
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
19. [Stem cells in hematology and oncology].
Goldschmidt H; Egerer G; Fruehauf S; Ho AD
Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
[TBL] [Abstract][Full Text] [Related]
20. [Transplantation of circulating hemopoietic stem cells, alternative to bone marrow transplantation?].
Remes K; Rajamäki A
Duodecim; 1994; 110(8):773-5. PubMed ID: 8586034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
